Home » Stocks » IBER

Ibere Pharmaceuticals (IBER)

Ibere Pharmaceuticals currently trades with the ticker symbol IBERU
Stock Price: $10.00 USD -0.04 (-0.40%)
Updated Mar 4, 2021 3:32 PM EST - Market closed
Market Cap 145.00M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 14.50M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 4
Last Price $10.00
Previous Close $10.04
Change ($) -0.04
Change (%) -0.40%
Day's Open -
Day's Range 10.00 - 10.01
Day's Volume -
52-Week Range 10.00 - 10.17

News

Hide News
PRNewswire - 2 days ago

Ibere Pharmaceuticals (the "Company") announced today that it closed its initial public offering of 13,800,000 units at $10.00 per unit, which...

NASDAQ - 3 weeks ago

Ibere Pharmaceuticals, a blank check company formed by PIPV Capital targeting pharmaceutical or life science businesses, filed on Tuesday with the SEC to raise up to $100 million in an initial...

SEC - 3 weeks ago

Ibere Pharmaceuticals has filed to go public with an IPO on the New York Stock Exchange (NYSE).

About IBER

Ibere Pharmaceuticals is a blank check company whose business purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. Ibere Pharmaceuticals is targeting a large addressable market as total worldwide prescription drug sales lost due to patent expiration from 2020 through 2026 is expected to be approximately $252 billion, according to EvaluatePharma. Our management team has a combined track record of over 100 years of successfully identifying, ac... [Read more...]

Industry
Blank Checks / SPAC
IPO Date
Feb 26, 2021
CEO
Osagie Imasogie
Country
United States
Stock Exchange
NYSE
Ticker Symbol
IBER
Full Company Profile